PTHS
Pelthos Therapeutics·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PTHS fundamentals
Pelthos Therapeutics (PTHS) released its earnings on Nov 13, 2025: revenue was 7.41M (YoY 0.00%), beat estimates; EPS was -5.3 (YoY -1727.59%), missed estimates.
Revenue / YoY
7.41M
0.00%
EPS / YoY
-5.3
-1727.59%
Report date
Nov 13, 2025
PTHS Earnings Call Summary for Q3,2025
- ZELSUVMI launch success: $7.1M Q3 revenue, 41% month-over-month growth in October prescriptions.
- Sales force expansion: Adding 14 reps to cover major cities, targeting 64 reps by Q1 2026.
- Xepi acquisition: $18M convertible notes financing to accelerate launch of complementary impetigo treatment.
- Financial targets: Cash flow breakeven by end-2026, $175M peak ZELSUVMI revenue by 2028.
- Market dynamics: No seasonal trends, but holiday-related office closures may impact Q4 growth.
EPS
Revenue
Revenue & Expenses
PTHS has released its 2025 Q3 earnings report, with revenue of 7.41M, reflecting a YoY change of NaN%, and net profit of -16.24M, showing a YoY change of -857.99%. The Sankey diagram below clearly presents PTHS's revenue sources and cost distribution.
Key Indicators
Pelthos Therapeutics (PTHS) key financial stats and ratios, covering profitability, financial health, and leverage.
Pelthos Therapeutics (PTHS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Pelthos Therapeutics (PTHS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Pelthos Therapeutics (PTHS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Pelthos Therapeutics (PTHS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Pelthos Therapeutics (PTHS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Pelthos Therapeutics's revenue and profit?Did Pelthos Therapeutics beat or miss consensus estimates last quarter?What is Pelthos Therapeutics's gross profit margin?What were the key takeaways from Pelthos Therapeutics’s earnings call?What is Pelthos Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for Pelthos Therapeutics next quarter?What guidance did Pelthos Therapeutics's management provide for the next earnings period?What does Pelthos Therapeutics do and what are its main business segments?
